Advertisement

Topics

2015 Emerging Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products

01:57 EDT 3 Jun 2015 | BioPortfolio

This article has expired, however you can still download the PDF.
Preview:
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing n....

Other Sources for this Article

Original Article: 2015 Emerging Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products

NEXT ARTICLE

More From BioPortfolio on "2015 Emerging Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...